MF PHARMA
ActiveSummary
MF PHARMA has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €15,747 and a net result of €34,505. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 35% of 22,382 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.9% (low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
14-04
NBB filing
Annual accounts filed
financial year 2025 · micro format
25-03
Gazette deed
Registered officeRegistered-office move2 facts ▸
Gazette deed
Registered office
Registered-office move2 facts ▸
- Board meeting, 03-03-2026
- Registered-office move, 4000 LIEGE Quai de Rome 48/51
2025
10-07
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial
Highest result from 2022 to 2025net €39,953 ▲66.6%
Operating result €50,603, net result €39,953, both a record.
10-07
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
11-07
NBB filing
Annual accounts filed
financial year 2022 · micro format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 2 deeds read
About the unread acts
Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.